| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/14/2005 | DE10131145B4 Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen Composition for cell-specific transfer of drugs |
| 07/14/2005 | DE10035620B4 Verwendung von Taurin als neuroprotektives Agens in der Ophthalmologie Use of taurine as a neuroprotective agent in ophthalmology |
| 07/14/2005 | DE10022095B4 Gel aus einem Poly-α-1,4-Glucan und Stärke Gel of a poly-α-1,4-glucan and starch |
| 07/14/2005 | CA2552311A1 Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 07/14/2005 | CA2552271A1 Proteoliposomes and its derivatives as adjuvants inducers of citotoxic response and the resultant formulations |
| 07/14/2005 | CA2551662A1 Multiparticulate formulations for oral delivery |
| 07/14/2005 | CA2551581A1 Probiotic tablet formulations |
| 07/14/2005 | CA2551510A1 Stable growth hormone liquid formulation |
| 07/14/2005 | CA2550983A1 Enhanced absorption of modified release dosage forms |
| 07/14/2005 | CA2550866A1 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 07/14/2005 | CA2550864A1 Personal care implement containing a stable reactive skin care and cleansing composition |
| 07/14/2005 | CA2550647A1 Injectable phosphatidylcholine preparations |
| 07/14/2005 | CA2550374A1 Oral medicament delivery system comprising collagen-based fibrous matrix |
| 07/14/2005 | CA2550351A1 Multiphase active ingredient formulation |
| 07/14/2005 | CA2550342A1 Effervescent preparation of a basic medicinal substance |
| 07/14/2005 | CA2549599A1 Pregabalin composition |
| 07/14/2005 | CA2549557A1 Drug delivery device with suture ring |
| 07/14/2005 | CA2549462A1 Self-microemulsifying drug delivery systems of a hiv protease inhibitor |
| 07/14/2005 | CA2549333A1 Treatment of ophthalmic conditions |
| 07/14/2005 | CA2548363A1 Pharmaceutical formulations of bisphosphonates |
| 07/14/2005 | CA2548305A1 Use of alginate matrices to control cell growth |
| 07/14/2005 | CA2544895A1 Liposomes and liposomal compositions for vaccination and drug delivery |
| 07/14/2005 | CA2544893A1 Synergistic liposomal adjuvants |
| 07/13/2005 | EP1552857A1 Apparatus for dispensing medicaments |
| 07/13/2005 | EP1552851A1 Rapidly disintegrating tablet and process for producing the same |
| 07/13/2005 | EP1552848A1 Compositions against chicken coccidiosis |
| 07/13/2005 | EP1552846A2 Use of heparinases to decrease inflammatory responses |
| 07/13/2005 | EP1552841A1 Arsenic sulfide compounds and derivates thereof for the treatment of malignancies |
| 07/13/2005 | EP1552839A1 Separate type medical material |
| 07/13/2005 | EP1552835A1 Transdermal patch for external use comprising fentanyl |
| 07/13/2005 | EP1552833A1 Stable solid preparations |
| 07/13/2005 | EP1552832A1 Process for producing coated preparation |
| 07/13/2005 | EP1552823A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/13/2005 | EP1552822A1 Patch |
| 07/13/2005 | EP1552821A1 Liner for sticking plaster |
| 07/13/2005 | EP1552820A1 Aqueous dispersion of nanocapsules with an oily core and method of preparing it |
| 07/13/2005 | EP1552819A2 Porous film forming granules, process for their preparation and application for coating tablets and sweets |
| 07/13/2005 | EP1552818A1 Release sustaining composition and sustained release preparation |
| 07/13/2005 | EP1552745A1 Therapeutic combinations of venous dilators and arterial dilators |
| 07/13/2005 | EP1551930A1 Edible inks for ink-jet printing on edible substrates |
| 07/13/2005 | EP1551899A1 Biodegradable phase separated segmented multi block co-polymers |
| 07/13/2005 | EP1551763A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 07/13/2005 | EP1551570A2 Solid flowable powder with high liquid loading |
| 07/13/2005 | EP1551566A1 Precipitation of solid particles from droplets formed using focused acoustic energy |
| 07/13/2005 | EP1551557A1 Method and apparatus for applying powder in a pattern to a substrate |
| 07/13/2005 | EP1551493A1 Minimally compliant, volume efficient piston for osmotic drug delivery systems |
| 07/13/2005 | EP1551478A1 Threaded syringe with quick stop |
| 07/13/2005 | EP1551459A1 Microbubble compositions, and methods for preparing and using same |
| 07/13/2005 | EP1551457A1 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/13/2005 | EP1551455A2 Product and process for liquefaction of mucus or sputum |
| 07/13/2005 | EP1551436A2 Formulations for amylin agonist peptides |
| 07/13/2005 | EP1551427A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/13/2005 | EP1551426A2 Methods of administering fgf18 |
| 07/13/2005 | EP1551425A2 Therapeutic formulations |
| 07/13/2005 | EP1551417A2 Three layer tear formulation |
| 07/13/2005 | EP1551416A2 Method for treating erectile dysfunction and increasing libido in men |
| 07/13/2005 | EP1551408A1 4-(4-methylpiperazin-1-ylmethyl)-n- 4-pyridin-3-yl)pyrimidin -2-ylamino)phenyl -benzamide for treating anaplastic thyroid cancer |
| 07/13/2005 | EP1551402A2 Abuse-resistant pharmaceutical compositions |
| 07/13/2005 | EP1551401A2 Mannitol formulation for integrin receptor antagonist |
| 07/13/2005 | EP1551399A1 Method for topical treatment of eye disease and composition and device for said treatment |
| 07/13/2005 | EP1551391A1 Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid |
| 07/13/2005 | EP1551390A1 Levamisole, avermectins or similar in pyrrolidone solvent |
| 07/13/2005 | EP1551377A1 Edible phosphoprotein film |
| 07/13/2005 | EP1551376A2 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/13/2005 | EP1551375A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 07/13/2005 | EP1551374A1 Polymer composition and dosage forms comprising the same |
| 07/13/2005 | EP1551373A1 Use of molded bodies for external application |
| 07/13/2005 | EP1551372A1 Sequestering subunit and related compositions and metohds |
| 07/13/2005 | EP1551371A2 Stabilized nanoparticle formulations of camptotheca derivatives |
| 07/13/2005 | EP1551370A1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 07/13/2005 | EP1551368A1 Controlled release of anti-arrhythmic agents |
| 07/13/2005 | EP1551367A2 Breath freshening and oral cleansing product with cinnamaldehyde |
| 07/13/2005 | EP1551361A1 Oral composition providing enhanced oral hygiene properties |
| 07/13/2005 | EP1551356A2 Pravastatin pharmaceutical formulations and methods of their use |
| 07/13/2005 | EP1551330A1 Improvements in delivery technology |
| 07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1487418A4 Co-beadlet of dha and rosemary and methods of use |
| 07/13/2005 | EP1453557A4 Improved stent coating |
| 07/13/2005 | EP1414479A4 Peptide for regulation of tissue plasminogen activator |
| 07/13/2005 | EP1357898A4 Improved controlled release oral dosage form |
| 07/13/2005 | EP1248636B1 Dextrin containing compositions for prevention of adhesions |
| 07/13/2005 | EP1207860A4 Controlled release pellet formulation |
| 07/13/2005 | EP1202722B1 Uses of compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 07/13/2005 | EP1119363B1 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN2708894Y Ointment |
| 07/13/2005 | CN2708893Y Compound layer ointment |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1639228A Carbohydrate-modified polymers, compositions and uses related thereto |
| 07/13/2005 | CN1638834A Flow condition sensor for infusion device |
| 07/13/2005 | CN1638830A Metered dose inhaler for salmeterol xinafoate |
| 07/13/2005 | CN1638822A Compositions comprising undifferentiated fetal cells for the treatment of skin disorders |
| 07/13/2005 | CN1638819A Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/13/2005 | CN1638805A Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/13/2005 | CN1638804A Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
| 07/13/2005 | CN1638803A Tablets quickly disintegrating in oral cavity |
| 07/13/2005 | CN1638802A Percutaneous absorption promoters and compositions for treating athlete's foot |